Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease

被引:101
|
作者
Xu, Qi [1 ,3 ]
Langley, Monica [2 ]
Kanthasamy, Anumantha G. [2 ]
Reddy, Manju B. [1 ]
机构
[1] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA
[2] Iowa State Univ, Dept Biomed Sci, Ames, IA USA
[3] Shanghai Univ Tradit Chinese Med, Sch Publ Hlth, Shanghai, Peoples R China
来源
JOURNAL OF NUTRITION | 2017年 / 147卷 / 10期
关键词
Parkinson disease; EGCG; MPTP; ferroportin; oxidative stress; IRON ACCUMULATION; OXIDATIVE STRESS; BRAIN; NEURODEGENERATION; EXPRESSION; CHELATORS; DEFERIPRONE; FERROPORTIN; DYSFUNCTION; ACTIVATION;
D O I
10.3945/jn.117.255034
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Parkinson disease (PD) is a neurodegenerative disorder that has been associated with many factors, including oxidative stress, inflammation, and iron accumulation. The antioxidant, anti-inflammatory, and iron-chelating properties of epigallocatechin gallate (EGCG), a major polyphenol in green tea, may offer protection against PD. Objective: We sought to determine the neurorescue effects of EGCG and the role of iron in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD. Methods: We evaluated the neurorescue effect of EGCG (25 mg/kg, 7 d, oral administration) against MPTP-induced (20 mg/kg, 3 d, intraperitoneal injection) neurodegeneration in C57 male black mice. Thirty mice weighing similar to 25 g were divided into 3 groups: control, MPTP, and MPTP + EGCG. The neurorescue effect of EGCG was assessed with the use of motor behavior tests, neurotransmitter analysis, oxidative stress indicators, and iron-related protein expression. Results: Compared with the control group, MPTP treatment shortened the mice's latency to fall from the rotarod by 16% (P < 0.05), decreased the striatal dopamine concentration by 58% (P < 0.001) and dihydroxyphenylacetic acid by 35% (P < 0.05), and increased serum protein carbonyls by 71% (P = 0.07). However, EGCG rescued MPTP-induced neurotoxicity by increasing the rotational latency by 17% (P < 0.05) to a value similar to the control group. Striatal dopamine concentrations were 40% higher in the MPTP + EGCG group than in the MPTP group (P < 0.05), but the values were significantly lower than in the control group. Compared with the MPTP and control groups, mice in the MPTP + EGCG group had higher substantia nigra ferroportin expression (44% and 35%, respectively) (P < 0.05) but not hepcidin and divalent metal transporter 1 expression. Conclusion: Overall, our study demonstrated that EGCG regulated the iron-export protein ferroportin in substantia nigra, reduced oxidative stress, and exerted a neurorescue effect against MPTP-induced functional and neurochemical deficits in mice.
引用
下载
收藏
页码:1926 / 1931
页数:6
相关论文
共 50 条
  • [1] Epigallocatechin gallate for Parkinson's disease
    Sergi, Consolato M.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (10) : 1029 - 1041
  • [2] Neurorescue Effect of EGCG in an Animal Model of Parkinson's Disease
    Xu, Qi
    Langley, Monica
    Kanthasamy, Anumantha
    Reddy, Manju
    FASEB JOURNAL, 2016, 30
  • [3] Therapeutic effect of epigallocatechin gallate in a mouse model of colitis.
    Abboud, PA
    Hake, PW
    Burroughs, TJ
    Odoms, K
    O'Connor, M
    Wong, HR
    Zingarelli, B
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A21 - A21
  • [4] Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis
    Abboud, Patricia A.
    Hake, Paul W.
    Burroughs, Timothy J.
    Odoms, Kelli
    O'Connor, Michael
    Mangeshkar, Prajakta
    Wong, Hector R.
    Zingarelli, Basilia
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 579 (1-3) : 411 - 417
  • [5] Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease
    Zhao, Qing
    Gao, Junpeng
    Li, Wenwei
    Cai, Dingfang
    BRAIN RESEARCH, 2010, 1346 : 224 - 236
  • [6] (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
    Zhou, Tingting
    Zhu, Mengru
    Liang, Zhanhua
    MOLECULAR MEDICINE REPORTS, 2018, 17 (04) : 4883 - 4888
  • [7] Neuroprotective effect of green tea extract (-)-epigallocatechin-3-gallate in a preformed fibril-induced mouse model of Parkinson's disease
    Shen, Jianing
    Xie, Junhua
    Ye, Liyuan
    Mao, Jian
    Sun, Shihao
    Chen, Weiwei
    Wei, Sijia
    Ruan, Sisi
    Wang, Linhai
    Hu, Hangcui
    Wei, Jingjing
    Zheng, Yao
    Xi, Zhouyan
    Wang, Ke
    Xu, Yan
    NEUROREPORT, 2024, 35 (06) : 421 - 430
  • [8] The application of proteomics for studying the neurorescue activity of the polyphenol (-)-epigallocatechin-3-gallate
    Weinreb, Orly
    Amit, Tamar
    Youdim, Moussa B. H.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2008, 476 (02) : 152 - 160
  • [9] Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma
    Shen, Ceying
    Chen, Lanlan
    Jiang, Libin
    Lai, Timothy Y. Y.
    NEUROSCIENCE LETTERS, 2015, 600 : 132 - 136
  • [10] The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
    Koh, SH
    Lee, SM
    Kim, HY
    Lee, KY
    Lee, YJ
    Kim, HT
    Kim, J
    Kim, MH
    Hwang, MS
    Song, C
    Yang, KW
    Lee, KW
    Kim, SH
    Kim, OH
    NEUROSCIENCE LETTERS, 2006, 395 (02) : 103 - 107